(805) 483 1185

English
Español
01 Fomat_Logo_Website-min
  • Home
  • Join a Trial
    • Join a Trial
    • Healthy Volunteers
    • Participant Stories
  • Sponsors
    • Phase I Capabilities
    • Phase II- IV Capabilities
    • Diversity
  • About Us
    • About Us
    • Our Investigators
    • Careers
    • Diversity
  • Resources
    • Company Updates
    • Blogs & Updates
    • Events and Conferences
  • Contact FOMAT

Home » FDA

Posts tagged: FDA

Novavax

Novavax Secures $1.6 Billion from U.S. Government for COVID-19 Vaccine Program

July 7, 2020
by Beatriz Morales

With rising numbers of COVID-19 infections and as the fight against the novel coronavirus continues, Novavax received $1.6 billion in federal funding to support the clinical development of the company’s vaccine candidate, NVX‑CoV2373. Gaithersburg ...

Read More
0
FDA

FDA Action Alert: Viela, Merck, Epizyme, Evoke and Regeneron

June 9, 2020
by Beatriz Morales

The next two weeks are busy ones for the U.S. Food and Drug Administration (FDA). Here’s a look at PDUFA dates for this period. Viela Bio’s Inebilizumab for NMOSD Gaithersburg, Maryland-based Viela Bio has a target action date of June 11 for its Bi ...

Read More
0
FDA Approvals Illustration Medical Devices and Drug Approvals

Faster Drug & Medical Device Approvals Under 21st Century Cures Act Raises Patient Safety Concerns

January 16, 2017
by Beatriz Morales

President Obama signed a bill that will provide US$6 billion in federal funding for basic medical research on Dec. 13. Called the 21st Century Cures Act, it also introduces changes to how the Food and Drug Administration approves drugs and medical de ...

Read More
0
Biosimilar drugs

FDA Endorses First Low Cost Biotech Drug

January 9, 2015
by Beatriz Morales

Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market. A panel of Food and Drug Administration experts ruled that the company's version of Neu ...

Read More
0
Experimental Antiviral Drug

Chimerix Gets FDA OK to Test Drug for Ebola

October 20, 2014
by Beatriz Morales

 A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration. Chimerix Inc. said that it has received FDA clearance to proceed wi ...

Read More
0
Experimental Antiviral Drug

Experimental Drug Provided to Dallas Ebola Patient

October 8, 2014
by Beatriz Morales

A North Carolina drugmaker is providing its experimental antiviral drug to a Dallas patient being treated for Ebola, an emergency step authorized by the Food and Drug Administration.  Officials at Texas Health Presbyterian Hospital said Monday that ...

Read More
0
Biosimilar drugs

Vivolux Cancer Drug Receives FDA Clearance for Clinical Study

October 8, 2014
by Beatriz Morales

Vivolux, a pharmaceutical company specialized in cancer treatment, announced that the FDA has granted clearance to proceed with VLX1570 Clinical Trial phase 1/2 for treatment against relapsed and/or refractory multiple myeloma. Researchers at Vivolux ...

Read More
0
Biosimilar drugs

FDA: Little Evidence to Support Testosterone Drugs

September 4, 2014
by Beatriz Morales

The Food and Drug Administration says there is little evidence that testosterone-boosting drugs taken by millions of American men are beneficial, though the agency is also unconvinced by studies suggesting the hormone carries serious testosterone the ...

Read More
0
Aids Activism Illustration of Discrimination Crowds Gather to Protest

AIDS Activist Fights for FDA

August 20, 2014
by Beatriz Morales

In this July 22, 2014 photo, AIDS activist Gregg Gonsalves walks outside Grand Central Terminal during a photo session, in New York. In the early 1990s, Gonsalves traveled to Washington to confront, provoke and challenge officials at the Food and Dru ...

Read More
0
Biosimilar drugs

FDA Approves Inhalable Diabetes Drug Afrezza

July 1, 2014
by Beatriz Morales

The Food and Drug Administration on Friday approved a long-delayed inhalable diabetes medication to help patients control their blood sugar levels during meals. The FDA cleared MannKind Corp.'s Afrezza, a fast-acting form of insulin for mealtime u ...

Read More
  • 1
  • 2
  • Next
  • Last

Contact Us

    Upcoming Events

    ASCO

    May 30 - June 3rd, 2025

    Chicago, IL

    Global SCRS

    Sep 29 - Oct 1, 2025

    Orlando, FL

    AAO 2025​

    Oct 18-20, 2025​

    Orlando, FL

    Full Event List
    • Review us on Google
    • Review us on Yelp

    Conditions & Theraputic Areas

    Join a Trial

    Healthy Volunteers

    Sponsors

    Phase I Capabilities

    Phase II & III Capabilities

    Diversity

    About Us

    Careers

    Investigators

    Contact Us

    • Review us on Google
    • Review us on Yelp

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: [email protected]
    General Information: [email protected]

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: [email protected]
    General Information: [email protected]
    • Review us on Google
    • Review us on Yelp
    Proud Partner of hyperCORE
    Facebook Linkedin Instagram
    Shopping Basket
    We use cookies to ensure the best possible experience on our website. By continuing to use this site, we will assume that you are happy with itAcceptPrivacy policy